JP

03 — PIPELINE

Turning insight into medical options.

We are advancing early diagnostic support and ultra-early disease prediction for intractable neurological diseases.

01
Neural cell icon

EARLY DIAGNOSTIC SUPPORT

Time iScan

Early diagnosis support

A development program designed to digitally analyze disease-specific changes in patient iPS cells and support earlier diagnosis.

Target disease
ALS (amyotrophic lateral sclerosis)
Development status
In development
02
DNA icon

ULTRA-EARLY PREDICTION

Time gScan

Ultra-early disease prediction

A development program combining patient-derived cells with digital technology to predict disease changes before symptoms appear.

Target disease
Alzheimer's disease
Development status
In development

DEVELOPMENT PROGRESS

From research to implementation.

For Time iScan, we are advancing implementation studies through SaMD and PMDA consultations.

View development news ↗
  1. SaMD Consultation

    Consulted on pathways toward marketing authorization.

  2. PMDA Consultation

    Consultation covering medical devices and in vitro diagnostics.

  3. Continued implementation planning

    Advancing Time iScan based on regulatory guidance.